Low Centyl K
*Company:
Karo Pharma ABStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 21 November 2025
File name
PL 20231027 Centyl K 1.25 mg IE.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Section 2: addition of interaction with medicines which decrease sodium levels
Section 4: update to details for reporting side effects
Section 6: removal of medical information email address
Section 6: update to date of revision
Updated on 21 November 2025
File name
SmPC-20231027-Centyl K 1.25 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.4: addition of warning for hyponatraemia
Section 4.5: addition of interaction with drugs decreasing sodium levels
Section 4.6: update to subheadings
Section 4.8: update to adverse reaction reporting details
Section 10: update to date of revision
Updated on 22 February 2023
File name
PL 20220214 Centyl K 1.25 mg IE.doc.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 21 February 2023
File name
SmPC-Centyl K 1.25 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Uploading anew to comply with the correct format
Updated on 21 February 2023
File name
PL-Centyl K 1.25mg-ie.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 17 December 2020
File name
SmPC-Centyl K 1.25 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 17 December 2020
File name
PL-Centyl K 1.25mg-ie.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 09 July 2019
File name
SmPC-201903-Centyl K 1.25 mg-ie.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 27 March 2019
File name
PL-201903-Centyl K 1.25 mg-ie.pdf
Reasons for updating
- New PIL for new product
Karo Pharma AB
Address:
Box 16184, 103 24 Stockholm, SwedenMedical Information E-mail:
MedinfoIE@karopharma.comTelephone:
+46 10 330 2310Website:
https://www.karopharma.com/Medical Information Direct Line:
+44 (0) 1628 531171Stock Availability:
supply@karopharma.se